Recombinant Anti-LEF1 antibody [EPR2029Y] (ab137872)

Rabbit recombinant monoclonal LEF1 antibody [EPR2029Y]. Validated in WB, IP, IHC, Flow Cyt, ICC/IF and tested in Mouse, Rat, Human. Cited in 15 publication(s). Independently reviewed in 1 review(s).

Publishing research using ab137872? Please let us know so that we can cite the reference in this datasheet.

ab137872 has been referenced in 18 publications.

  • Ji Q  et al. Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis. Nat Commun 10:313 (2019). WB, IP ; Saccharomyces cerevisiae . PubMed: 30659184
  • Huang X  et al. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/ß-catenin signaling. IUBMB Life 71:223-234 (2019). PubMed: 30452118
  • Pizzi M  et al. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma. Hum Pathol 85:251-259 (2019). PubMed: 30458196
  • Liu XY  et al. FGF-7 Dictates Osteocyte Cell Processes Through Beta-Catenin Transduction. Sci Rep 8:14792 (2018). PubMed: 30287900
  • Przybyl J  et al. Gene expression profiling of low-grade endometrial stromal sarcoma indicates fusion protein-mediated activation of the Wnt signaling pathway. Gynecol Oncol 149:388-393 (2018). IHC-P . PubMed: 29544705
  • Rasheduzzaman M  et al. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-?B signaling. Life Sci 208:208-220 (2018). PubMed: 30031063
  • Song J  et al. Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt/ß-catenin pathway in hepatocellular carcinoma. Theranostics 8:3571-3583 (2018). PubMed: 30026867
  • Zhao Y  et al. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration. Cancer Med 7:3977-3987 (2018). IHC-P ; Human . PubMed: 29974668
  • Mills F  et al. Cadherins mediate cocaine-induced synaptic plasticity and behavioral conditioning. Nat Neurosci 20:540-549 (2017). IHC-FoFr ; Mouse . PubMed: 28192395
  • O'Malley DP  et al. Expression of LEF1 in mantle cell lymphoma. Ann Diagn Pathol 26:57-59 (2017). IHC-P ; Human . PubMed: 28038713
  • Menter T  et al. Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas. Am J Clin Pathol 147:292-300 (2017). IHC ; Human . PubMed: 28395058
  • Li P  et al. Clinical significance and biological role of Wnt10a in ovarian cancer. Oncol Lett 14:6611-6617 (2017). WB ; Human . PubMed: 29163692
  • Li FF  et al. Different effection of p.1125Val>Ala and rs11954856 in APC on Wnt signaling pathway. Oncotarget 8:70854-70864 (2017). WB ; Human . PubMed: 29050326
  • Dräger J  et al. LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcoma. Oncotarget 8:3259-3273 (2017). IHC-P ; Human . PubMed: 27965462
  • Siddiqi IN  et al. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol 29:570-81 (2016). IHC ; Human . PubMed: 26965583
  • Tandon B  et al. Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle? Leuk Lymphoma 56:3378-86 (2015). IHC ; Human . PubMed: 25860247
  • Tandon B  et al. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol 24:1433-43 (2011). IHC ; Human . PubMed: 21685909
  • Geissinger E  et al. Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations. Haematologica 95:1697-704 (2010). IHC-P ; Human . PubMed: 20511667

For licensing inquiries, please contact

Sign up